Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    18375894 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed S9626: Megestrol in Treating Hot Flashes Following Treatment for Breast Cancer
Conditions: Breast Cancer;   Hot Flashes
Interventions: Drug: Megestrol Acetate 20mg/day;   Drug: Megestrol Acetate 40 mg/day;   Drug: Megestrol Acetate Placebo 20 mg/day;   Drug: Megestrol Acetate Placebo 40 mg/day

Indicates status has not been verified in more than two years